Cargando…
Short-term physiological hypoxia potentiates the therapeutic function of mesenchymal stem cells
BACKGROUND: In the bone marrow, MSCs reside in a hypoxic milieu (1–5% O(2)) that is thought to preserve their multipotent state. Typically, in vitro expansion of MSCs is performed under normoxia (~ 21% O(2)), a process that has been shown to impair their function. Here, we evaluated the characterist...
Autores principales: | Antebi, Ben, Rodriguez, Luis A, Walker, Kerfoot P, Asher, Amber M, Kamucheka, Robin M, Alvarado, Lucero, Mohammadipoor, Arezoo, Cancio, Leopoldo C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180371/ https://www.ncbi.nlm.nih.gov/pubmed/30305185 http://dx.doi.org/10.1186/s13287-018-1007-x |
Ejemplares similares
-
Preconditioning in an Inflammatory Milieu Augments the Immunotherapeutic Function of Mesenchymal Stromal Cells
por: Rodriguez, Luis A., et al.
Publicado: (2019) -
Mesenchymal Stem Cells Reconditioned in Their Own Serum Exhibit Augmented Therapeutic Properties in the Setting of Acute Respiratory Distress Syndrome
por: Xu, Amy L., et al.
Publicado: (2019) -
Therapeutic potential of products derived from mesenchymal stem/stromal cells in pulmonary disease
por: Mohammadipoor, Arezoo, et al.
Publicado: (2018) -
Cryopreserved mesenchymal stem cells regain functional potency following a 24-h acclimation period
por: Antebi, Ben, et al.
Publicado: (2019) -
The effect of acute respiratory distress syndrome on bone marrow-derived mesenchymal stem cells
por: Antebi, Ben, et al.
Publicado: (2018)